The U.S. Food and Drug Administration (FDA) has cleared Imeka's Advanced Neuro Diagnostic Imaging (ANDI) software.
ANDI processes diffusion-weighted images from brain imaging using reconstruction algorithms such as modeling, tractography, and fiber bundling to map microstructural properties of the white matter and creates maps that analyze the microstructural properties of white matter, Imeka said.
